The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Quick-acting Asthma Medicine-Global Market Insights and Sales Trends 2024
Synopsis
Quick-acting asthma medicine refers to a type of medication that provides immediate relief of asthma symptoms, particularly acute episodes of shortness of breath, wheezing, coughing, and chest tightness. These medications are also known as rescue or reliever inhalers. They work by relaxing the muscles around the airways and reducing inflammation, allowing the air passages to open up and making breathing easier.
The global Quick-acting Asthma Medicine market size is expected to reach US$ 31050 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Quick-acting Asthma Medicine in various end use industries. The expanding demands from the Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others, are propelling Quick-acting Asthma Medicine market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Spray segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Quick-acting Asthma Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Quick-acting Asthma Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Quick-acting Asthma Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Quick-acting Asthma Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Quick-acting Asthma Medicine covered in this report include Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical and Vectura Group, etc.
The global Quick-acting Asthma Medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
Global Quick-acting Asthma Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Quick-acting Asthma Medicine market, Segment by Type:
Tablet
Spray
Global Quick-acting Asthma Medicine market, by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Quick-acting Asthma Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Quick-acting Asthma Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Quick-acting asthma medicine refers to a type of medication that provides immediate relief of asthma symptoms, particularly acute episodes of shortness of breath, wheezing, coughing, and chest tightness. These medications are also known as rescue or reliever inhalers. They work by relaxing the muscles around the airways and reducing inflammation, allowing the air passages to open up and making breathing easier.
The global Quick-acting Asthma Medicine market size is expected to reach US$ 31050 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Quick-acting Asthma Medicine in various end use industries. The expanding demands from the Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others, are propelling Quick-acting Asthma Medicine market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Spray segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Quick-acting Asthma Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Quick-acting Asthma Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Quick-acting Asthma Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Quick-acting Asthma Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Quick-acting Asthma Medicine covered in this report include Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical and Vectura Group, etc.
The global Quick-acting Asthma Medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
Global Quick-acting Asthma Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Quick-acting Asthma Medicine market, Segment by Type:
Tablet
Spray
Global Quick-acting Asthma Medicine market, by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Quick-acting Asthma Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Quick-acting Asthma Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Quick-acting Asthma Medicine Market Overview
1.1 Quick-acting Asthma Medicine Product Overview
1.2 Quick-acting Asthma Medicine Market Segment by Type
1.2.1 Tablet
1.2.2 Spray
1.3 Global Quick-acting Asthma Medicine Market Size by Type
1.3.1 Global Quick-acting Asthma Medicine Market Size Overview by Type (2018-2029)
1.3.2 Global Quick-acting Asthma Medicine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Quick-acting Asthma Medicine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Quick-acting Asthma Medicine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Quick-acting Asthma Medicine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Quick-acting Asthma Medicine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Quick-acting Asthma Medicine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Quick-acting Asthma Medicine Sales Breakdown by Type (2018-2023)
2 Global Quick-acting Asthma Medicine Market Competition by Company
2.1 Global Top Players by Quick-acting Asthma Medicine Sales (2018-2023)
2.2 Global Top Players by Quick-acting Asthma Medicine Revenue (2018-2023)
2.3 Global Top Players by Quick-acting Asthma Medicine Price (2018-2023)
2.4 Global Top Manufacturers Quick-acting Asthma Medicine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Quick-acting Asthma Medicine Market Competitive Situation and Trends
2.5.1 Quick-acting Asthma Medicine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Quick-acting Asthma Medicine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Quick-acting Asthma Medicine as of 2022)
2.7 Date of Key Manufacturers Enter into Quick-acting Asthma Medicine Market
2.8 Key Manufacturers Quick-acting Asthma Medicine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Quick-acting Asthma Medicine Status and Outlook by Region
3.1 Global Quick-acting Asthma Medicine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Quick-acting Asthma Medicine Historic Market Size by Region
3.2.1 Global Quick-acting Asthma Medicine Sales in Volume by Region (2018-2023)
3.2.2 Global Quick-acting Asthma Medicine Sales in Value by Region (2018-2023)
3.2.3 Global Quick-acting Asthma Medicine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Quick-acting Asthma Medicine Forecasted Market Size by Region
3.3.1 Global Quick-acting Asthma Medicine Sales in Volume by Region (2024-2029)
3.3.2 Global Quick-acting Asthma Medicine Sales in Value by Region (2024-2029)
3.3.3 Global Quick-acting Asthma Medicine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Quick-acting Asthma Medicine by Application
4.1 Quick-acting Asthma Medicine Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Online Pharmacy
4.1.3 Retail Pharmacy
4.1.4 Others
4.2 Global Quick-acting Asthma Medicine Market Size by Application
4.2.1 Global Quick-acting Asthma Medicine Market Size Overview by Application (2018-2029)
4.2.2 Global Quick-acting Asthma Medicine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Quick-acting Asthma Medicine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Quick-acting Asthma Medicine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Quick-acting Asthma Medicine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Quick-acting Asthma Medicine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Quick-acting Asthma Medicine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Quick-acting Asthma Medicine Sales Breakdown by Application (2018-2023)
5 North America Quick-acting Asthma Medicine by Country
5.1 North America Quick-acting Asthma Medicine Historic Market Size by Country
5.1.1 North America Quick-acting Asthma Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Quick-acting Asthma Medicine Sales in Volume by Country (2018-2023)
5.1.3 North America Quick-acting Asthma Medicine Sales in Value by Country (2018-2023)
5.2 North America Quick-acting Asthma Medicine Forecasted Market Size by Country
5.2.1 North America Quick-acting Asthma Medicine Sales in Volume by Country (2024-2029)
5.2.2 North America Quick-acting Asthma Medicine Sales in Value by Country (2024-2029)
6 Europe Quick-acting Asthma Medicine by Country
6.1 Europe Quick-acting Asthma Medicine Historic Market Size by Country
6.1.1 Europe Quick-acting Asthma Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Quick-acting Asthma Medicine Sales in Volume by Country (2018-2023)
6.1.3 Europe Quick-acting Asthma Medicine Sales in Value by Country (2018-2023)
6.2 Europe Quick-acting Asthma Medicine Forecasted Market Size by Country
6.2.1 Europe Quick-acting Asthma Medicine Sales in Volume by Country (2024-2029)
6.2.2 Europe Quick-acting Asthma Medicine Sales in Value by Country (2024-2029)
7 Asia-Pacific Quick-acting Asthma Medicine by Region
7.1 Asia-Pacific Quick-acting Asthma Medicine Historic Market Size by Region
7.1.1 Asia-Pacific Quick-acting Asthma Medicine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Quick-acting Asthma Medicine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Quick-acting Asthma Medicine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Quick-acting Asthma Medicine Forecasted Market Size by Region
7.2.1 Asia-Pacific Quick-acting Asthma Medicine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Quick-acting Asthma Medicine Sales in Value by Region (2024-2029)
8 Latin America Quick-acting Asthma Medicine by Country
8.1 Latin America Quick-acting Asthma Medicine Historic Market Size by Country
8.1.1 Latin America Quick-acting Asthma Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Quick-acting Asthma Medicine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Quick-acting Asthma Medicine Sales in Value by Country (2018-2023)
8.2 Latin America Quick-acting Asthma Medicine Forecasted Market Size by Country
8.2.1 Latin America Quick-acting Asthma Medicine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Quick-acting Asthma Medicine Sales in Value by Country (2024-2029)
9 Middle East and Africa Quick-acting Asthma Medicine by Country
9.1 Middle East and Africa Quick-acting Asthma Medicine Historic Market Size by Country
9.1.1 Middle East and Africa Quick-acting Asthma Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Quick-acting Asthma Medicine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Quick-acting Asthma Medicine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Quick-acting Asthma Medicine Forecasted Market Size by Country
9.2.1 Middle East and Africa Quick-acting Asthma Medicine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Quick-acting Asthma Medicine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Quick-acting Asthma Medicine Products Offered
10.1.5 Pfizer Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GlaxoSmithKline Quick-acting Asthma Medicine Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Quick-acting Asthma Medicine Products Offered
10.3.5 Novartis Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Quick-acting Asthma Medicine Products Offered
10.4.5 Merck Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Boehringer Ingelheim Quick-acting Asthma Medicine Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information
10.6.2 AstraZeneca Introduction and Business Overview
10.6.3 AstraZeneca Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 AstraZeneca Quick-acting Asthma Medicine Products Offered
10.6.5 AstraZeneca Recent Development
10.7 Roche
10.7.1 Roche Company Information
10.7.2 Roche Introduction and Business Overview
10.7.3 Roche Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Roche Quick-acting Asthma Medicine Products Offered
10.7.5 Roche Recent Development
10.8 Teva Pharmaceutical
10.8.1 Teva Pharmaceutical Company Information
10.8.2 Teva Pharmaceutical Introduction and Business Overview
10.8.3 Teva Pharmaceutical Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Teva Pharmaceutical Quick-acting Asthma Medicine Products Offered
10.8.5 Teva Pharmaceutical Recent Development
10.9 Vectura Group
10.9.1 Vectura Group Company Information
10.9.2 Vectura Group Introduction and Business Overview
10.9.3 Vectura Group Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Vectura Group Quick-acting Asthma Medicine Products Offered
10.9.5 Vectura Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Quick-acting Asthma Medicine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Quick-acting Asthma Medicine Industrial Chain Analysis
11.4 Quick-acting Asthma Medicine Market Dynamics
11.4.1 Quick-acting Asthma Medicine Industry Trends
11.4.2 Quick-acting Asthma Medicine Market Drivers
11.4.3 Quick-acting Asthma Medicine Market Challenges
11.4.4 Quick-acting Asthma Medicine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Quick-acting Asthma Medicine Distributors
12.3 Quick-acting Asthma Medicine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
